Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11
Closed -$598 2032
2022
Q4
$598 Hold
11
﹤0.01% 1596
2022
Q3
$0 Hold
11
﹤0.01% 1808
2022
Q2
$1K Sell
11
-372
-97% -$18.1K ﹤0.01% 1305
2022
Q1
$20K Sell
383
-6
-2% -$310 ﹤0.01% 744
2021
Q4
$23K Sell
389
-15
-4% -$860 ﹤0.01% 685
2021
Q3
$22K Sell
404
-135
-25% -$7.52K ﹤0.01% 650
2021
Q2
$28K Buy
539
+73
+16% +$3.77K ﹤0.01% 581
2021
Q1
$24K Sell
466
-626
-57% -$34.4K ﹤0.01% 625
2020
Q4
$61K Buy
1,092
+521
+91% +$27.8K 0.01% 418
2020
Q3
$32K Buy
571
+46
+9% +$2.39K 0.01% 448
2020
Q2
$24K Buy
525
+29
+6% +$1.3K 0.01% 465
2020
Q1
$22K Buy
496
+173
+54% +$6.76K 0.01% 421
2019
Q4
$12K Buy
+323
New +$12K ﹤0.01% 507

Other funds holding QGEN

Ellevest Inc's QGEN Position: Q1 2023 in Review

Ellevest Inc sold out of Qiagen (QGEN) in Q1 2023, closing a stake of 11 shares — an estimated $598 sold.

Ellevest Inc first reported a position in QGEN in Q4 2019 and held it in 13 quarters. The position peaked at $61K in Q4 2020. 286 funds tracked by Wall St. Rank hold QGEN as of Q1 2023.

  • Ellevest Inc reported no remaining Qiagen position as of Q1 2023 after selling out during the quarter.
  • Ellevest Inc sold 11 Qiagen shares in Q1 2023, an estimated $598.
  • Ellevest Inc first reported a position in Qiagen in Q4 2019 and held it in 13 quarters.
  • Ellevest Inc's Qiagen position peaked at $61K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Qiagen as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.